您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

林樹福醫師

甲狀腺癌新的治療方法 、糖尿病肥胖症、、代謝症候群、甲狀腺及內分泌疾病、糖尿病足病變
  • 國語,英語,閩南語
  • 副教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 新北市立土城醫院內科部部主任
    • 新北市立土城醫院新陳代謝科科主任
    • 新北市立土城醫院新陳代謝科主治醫師
    • 長庚大學醫學系助理教授
  • 學歷
    • 中國醫藥大學醫學系
  • 經歷
    • 林口長庚醫院主治醫師,2004年7月-2020年4月
    • Memorial Sloan-Kettering Cancer Center, Research fellow: 2006年2月-2008年1月
    • 林口長庚醫院總醫師:2002年7月-2004年6月
    • 林口長庚醫院住院醫師:1999年7月-2002年6月
  • 學會與認證
    • 中華民國內分泌暨糖尿病專科醫師
    • 內科專科醫師
  • 論文及期刊發表
    • Lin SF, Chang SH, Kuo CF, Lin WT, Chiou MJ, Huang YT. Association of pregnancy outcomes in women with type 2 diabetes treated with metformin versus insulin when becoming pregnant. BMC Pregnancy and Childbirth. 2020-8 accepted (SCI).

    • Lin HT, Liu FC, Lin SF, Kuo CF, Chen YY, Yu HP. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study. J Clin Endocrinol Metab. 2020;105: e2521–e2530 (SCI).

    • Lin SF, Lin JD, Yeh CN, Huang YT, Chou TC, Wong RJ. Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer. Endocr Relat Cancer. 2019;26:727–738 (SCI).

    • Lin HT, Cheng ML, Lo CJ, Lin G, Lin SF, Yeh JT, Ho HY, Lin JR, Liu FC. 1H NMR-based cerebrospinal fluid and plasma metabolomic analysis in type 2 diabetic patients and risk prediction for diabetic microangiopathy. J Clin Med. 2019;8. pii: E874. doi: 10.3390/jcm8060874 (SCI).

    • Lin JD, Kuo SF, Huang BY, Lin SF, Chen ST. The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis. Nucl Med Commun. 2018;39:1091-1096 (SCI).

    • Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ. Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer. Endocrine-Related Cancer. 2018;25:853–864 (SCI).

    • Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ. Activity of roniciclib in medullary thyroid cancer. Oncotarget 2018; 9:28030-28041 (SCI).

    • Lin SF, Kuo CF, Chiou MJ, Chang SH. Maternal and Fetal Outcomes of Pregnant Women with Type 1 Diabetes, a National Population Study. Oncotarget. 2017; 8:80679-80687 (SCI).

    • Mann JFE, Orsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornoe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med. 2017;377:839-848 (SCI).

    • Liu FC, Lin HT, Lin SF, Kuo CF, Chung TT, Yu HP. Nationwide Cohort Study on the Epidemiology and Survival Outcomes of Thyroid Cancer. Oncotarget. 2017; 8:78429-78451 (SCI).

    • Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ. Effects of Roniciclib in Preclinical Models of Anaplastic Thyroid Cancer. Oncotarget 2017;8:67990-68000 (SCI).

    • Lin SF, Lin JD, Hsueh C, Chou TC, Yeh CN, Chen MH, Wong RJ. Efficacy of a HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models. Oncotarget 2017;8,41294-41304 (SCI).

    • Lin JD, Lin SF, Chen ST, Hsueh C, Chao TC. Long-term Follow-up of Papillary and Follicular Thyroid Carcinomas with Bone Metastasis. PLoS One 2017;12:e0173354 (SCI).

    • Lin SF, Lin JD, Hsueh C, Chou TC, Wong RJ. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer. PLoS One 2017;12:e0172315 (SCI).

    • Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375:311-22 (SCI).

    • Jianing Fu, Ning Zhang, Josep H. Chou; Hua-Jin Dong, Shu-Fu Lin, Gudrun S. Ulrich-Merzenich, Ting-Chao Chou. Drug Combination in Vivo Using Combination Index Method: Taxotere and T607 against Colon Carcinoma HCT-116 Xenograft Tumor in Nude Mice. Synergy 3 (2016) 15–30.

    • Chiang KC, Kuo SF, Chen CH, Ng S, Lin SF, Yeh CN, et al. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Cancer Lett. Cancer Lett. 2015;369:76-85. doi: 10.1016/j.canlet.2015.07.024 (SCI).

    • Chen CH, Chen WY, Lin SF, Wong RJ. Epithelial mesenchymal transition enhances response to oncolytic herpes viral therapy through nectin-1. Hum Gene Ther 2014 Jun; 25:539–551 (SCI).

    • Kuo SF, Lin SF, Chao TC, Hsueh C, Lin KJ, Lin JD. Prognosis of Multifocal Papillary Thyroid Carcinoma. Int J Endocrinol 2013;2013:809382. doi: 10.1155/2013/809382 (SCI).

    • Lin SF, Lin JD, Chou TC, Huang YY, Wong RJ. Utility of a Histone Deacetylase Inhibitor (PXD101) For Thyroid Cancer Treatment. PLoS ONE 2013;8(10): e77684. doi:10.1371/journal.pone.0077684 (SCI).

    • Lin SF, Huang YY, Lin JD, Chou TC, Hsueh C, Wong RJ. Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy. PLoS ONE 2012;7(10):e46726. doi:10.1371/journal.pone.0046726 (SCI).

    • Huang CH, Chao TC, Hseuh C, Lin KJ, Ho TY, Lin SF, Lin JD. Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer. Pediatr Surg Int. 2012;28:489-94 (SCI).

    • Tsai SS, Huang JC, Chen ST, Sun JH, Wang CC, Lin SF, Hsu BR, Lin JD, Huang SY, Huang YY. Characteristics of Klebsiella pneumoniae bacteremia in community-acquired and nosocomial infections in diabetic patients. Chang Gung Med J. 2010;33:532-9.

    • Dai MH, Zamarin D, Gao SP, Chou TC, Gonzalez L, Lin SF, Fong Y. Synergistic action of oncolytic herpes simplex virus and radiotherapy in pancreatic cancer cell lines. Br J Surg. 2010;97:1385-94 (SCI).

    • Price DL, Lin SF, Han Z, Simpson G, Coffin RS, Wong J, Li S, Fong Y, Wong RJ. Oncolysis using herpes simplex virus type 1 engineered to express cytosine deaminase and a fusogenic glycoprotein for head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136:151-8 (SCI).

    • Lin SF, Price DL, Chen CH, Brader P, Li S, Gonzalez L, Zhang Q, Yu YA, Chen N, Szalay AA, Fong Y, Wong RJ. Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancer In Vivo. J Clin Endocrinol Metab; 2008;93:4403-7 (SCI).

    • Kelly KJ, Woo Y, Brader P, Yu Z, Riedl C, Lin SF, Chen N, Yu YA, Rusch VW, Szalay AA, Fong Y. Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma. Hum Gene Ther 2008; 19:774-782 (SCI).

    • Yu Z, Li S, Huang YY, Lin SF, Fong Y, Wong RJ. Sensitivity of Squamous Cell Carcinoma Lymph Node Metastases to Herpes Oncolytic Therapy. Clin Cancer Res 2008;14:1897-1904 (SCI).

    • Lin SF, Gao SP, Price D, Li S, Chou TC, Singh P, Huang YY, Fong Y, Wong RJ. Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer. Clin Cancer Res 2008;14:1959-28 (SCI).

    • Lin SF, Yu Z, Riedl C, Woo Y, Zhang Q, Yu YA, Timiryasova T, Chen N, Shah JP, Szalay AA, Fong Y, Wong RJ. Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus. Surgery 2007;142:976-83 (SCI).

    • Huang YY, Yu Z, Lin SF, Li S, Fong F, Wong RJ. Nectin-1 Is a Marker of Thyroid Cancer Sensitivity to Herpes Oncolytic Therapy. J Clin Endocrinol Metab 2007;92:1965–70 (SCI).

    • Huang YY, Lin SF (Corresponding author), Dunn P, Wai YY, Hsueh C, Tsai JS. Primary pituitary lymphoma presenting as hypophysitis. Endocr J 2005;52:543-9 (SCI).

    • Lin SF, Lin JD, Huang YY. Diabetic ketoacidosis: comparisons of patient characteristics, clinical presentations and outcomes today and 20 years ago. Chang Gung Med J 2005;28:24-30.